CLINICAL_TRIALS
research
· 2016-07-27
Clinical Trial Update: Vascular Function Intervention Trial in Sickle Cell Disease [Phase 2, Phase 3]
Summary
This entry reports an ongoing vascular function intervention trial in sickle cell disease, listed as Phase 2 and Phase 3, with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Sickle Cell Disease | Phase 2, Phase 3 | Status: UNKNOWN